Modified Biophysical Profile Interpreter
Modified Biophysical Profile Interpreter
The heart rate tracing plus the amniotic fluid assessment, and nothing else. Two components in place of five, reported at the same false-negative rate in 1990s data – and the two are not measuring the same timescale, which is the reason it works.
Two components, not five
Tracing plus fluidReactive tracing, amniotic fluid at or above the oligohydramnios threshold, 34 completed weeks
Two components, and why these two
The other three components of the full profile — breathing, movement, tone — are not assessed
- why the tracing
- it is the component that reflects central nervous system state at the moment of testing, and it is the one that the gradual hypoxia model predicts is lost first, because it is the last to appear in development at about 28 weeks. It is also the only non-sonographic component
- why the fluid
- it is the only component that reflects a CHRONIC process rather than the state during the scan. The other three sonographic components all move with the same thing the tracing moves with, so they add less than their time costs. Two components on two different timescales carry most of what five carry
- the threshold the fluid component uses
- an open question, and the page will not pretend otherwise. Miller and colleagues’ protocol used the amniotic fluid index; ACOG supports the single deepest pocket of 2 cm or less; the full profile’s own criterion is a pocket of 2 cm in two perpendicular planes. The index calls oligohydramnios 2.39 times as often as the pocket. See the two methods compared
- what ‘modified’ means, and it means two things
- in current American usage it is the tracing plus the fluid. Manning’s own 1984 modification was different: there the tracing was performed ONLY IF one of the sonographic variables was abnormal, which is nearly the reverse arrangement. Other published modifications shorten the breathing criterion from 60 to 30 seconds, drop the tracing entirely, or compare observed behaviours against gestational-age nomograms. A report saying ‘modified biophysical profile’ needs to say which
- what it predicted
- a false-negative rate of 0.8 per 1000 women tested in Miller and colleagues’ 1990 to 1994 prospective series, which the authors said compares favourably with the contraction stress test and the complete profile and is lower than the tracing alone. The same series: 60% of those delivered for an abnormal test had no evidence of compromise, and 1.5% of those tested before term were delivered preterm because of a false positive
Worked example
Reactive tracing, amniotic fluid at or above the oligohydramnios threshold, 34 completed weeks
Gestational age 34 weeks, so reactivity is established and the tracing means what it says
Tracing reactive and fluid at or above threshold, so neither component is abnormal
Set the tracing non-reactive and the result changes to the heart rate component alone; set the fluid low instead and it changes to the fluid component alone; set both and it reports both
Set the gestational age to 27 weeks and the page says so rather than reporting a two-component result, because reactivity develops at about 28 weeks
The threshold behind the fluid component is not fixed: an index below 5 cm and a pocket below 2 cm are different findings on the same pregnancy 2.39 times as often as not
Five components against two
| Component | Full profile | Modified profile |
|---|---|---|
| Fetal heart rate reactivity | Scored 2 or 0 | Assessed |
| Amniotic fluid volume | Scored 2 or 0 | Assessed |
| Fetal breathing movements | Scored 2 or 0 | Not assessed |
| Gross body movements | Scored 2 or 0 | Not assessed |
| Fetal tone | Scored 2 or 0 | Not assessed |
| Result | A total of 0 to 10 in even numbers | Two findings, not a total |
What the modified profile has reported
| Figure | Value | Source and cohort |
|---|---|---|
| False-negative rate | 0.8 per 1000 women tested | Miller, Rabello and Paul, prospective 1990 to 1994 |
| Delivered for an abnormal test with no evidence of compromise | 60% | Same series |
| Preterm delivery from a false-positive result | 1.5% of those tested before term | Same series |
| The comparable full-profile figure | 0.8 per 1000 (ACOG), 0.68 per 1000 (GLOWM table) | Quoted guidance and a textbook table |
| The same full-profile figure, measured twice | 0.708 and 2.289 per 1000 at two centres | Dayal and colleagues, 86,955 patients over 18 years |
Why dropping three components costs so little
The full biophysical profile takes time: up to 30 minutes of continuous observation before any sonographic variable can be called absent, because fetal sleep-wake cycles produce absent breathing and absent movement in healthy fetuses. The modified profile keeps two components and drops three, and the argument for it is not that the three are worthless but that they are largely redundant.
The redundancy argument is about timescale. Breathing, movement and tone all reflect central nervous system state during the scan, and so does the heart rate tracing; they move together and they move for the same reasons, including reasons that are not hypoxia, such as maternal fasting, which reduces breathing movements. Amniotic fluid volume is the odd one out: it reflects a process running over days to weeks. So the pairing is one acute measure and one chronic measure, which is why two components carry most of what five carry. Miller, Rabello and Paul’s prospective series from 1990 to 1994 reported a false-negative rate of 0.8 per 1000 women tested, the same number ACOG quotes for the full profile, and the authors said it compared favourably with the contraction stress test and the complete profile and was better than the tracing alone.
Three things to hold alongside that. First, ‘modified’ is ambiguous in the literature and a report using the term needs to say which modification: current American usage is the tracing plus the fluid, but Manning’s own 1984 modification performed the tracing only if a sonographic variable was abnormal, and other published versions shorten the breathing criterion, drop the tracing, or score against gestational-age nomograms. Second, the fluid threshold is unsettled — Miller’s protocol used the amniotic fluid index, ACOG supports the single deepest pocket, and the index calls oligohydramnios 2.39 times as often across five randomised trials. Third, the same series that gives the 0.8 per 1000 also reports that 60% of those delivered for an abnormal antepartum test had no evidence of compromise. A test with a very good negative predictive value can still have a poor positive one, and both numbers come from the same paper. The tracing itself is classified by the NICHD three-tier system, and the gestational age that decides whether a non-reactive tracing means anything comes from the dating pages. This page computes a number, or applies published criteria, and names the body that publishes them. It renders no clinical decision: nothing here says whether this fetus is compromised, whether a tracing should be acted on, whether a scan should be repeated, whether labour should be induced or when a pregnancy should be delivered. An obstetric measurement is read alongside the whole clinical picture – history, gestational age, serial trend, the other biometry – and never instead of it. It supports a clinician’s judgement rather than replacing it.
Frequently asked questions
What exactly is the modified biophysical profile?
In current American usage, a fetal heart rate tracing plus an amniotic fluid assessment, with the other three components of the full profile not performed. Be careful with the term: Manning’s own 1984 modification was different, performing the tracing only if one of the sonographic variables was abnormal, and other published modifications shorten the breathing criterion, drop the tracing, or compare behaviours against gestational-age nomograms.
Why these two components?
Because they measure different timescales. Breathing, movement and tone all reflect central nervous system state during the scan, which is what the heart rate tracing reflects too, so they add less than the 30 minutes of observation they cost. Amniotic fluid volume is the only component reflecting a process over days to weeks.
Does the modified profile have a score?
No. It is two findings reported separately, not a total. This page reports them separately for that reason: a two-item total would hide which component was abnormal, and the two are not equivalent.
Which amniotic fluid threshold should be used?
The literature does not agree. Miller and colleagues’ original protocol used the amniotic fluid index; ACOG supports a single deepest pocket of 2 cm or less; and the full profile’s own criterion is a pocket of 2 cm in two perpendicular planes. Across five randomised trials and 3,226 women the index diagnosed oligohydramnios 2.39 times as often as the pocket, with 1.92 times as much induction of labour and no difference in neonatal intensive care admission.
Is a normal modified profile reassuring?
The published false-negative rate is 0.8 per 1000 women tested in one centre’s 1990s practice. Two cautions: a false-negative rate is a property of the population tested rather than of the test, and the full profile’s equivalent figure differed more than threefold between two centres in an 86,955-patient series. The same paper that reports 0.8 per 1000 also reports that 60% of those delivered for an abnormal test had no evidence of compromise.
Related calculators
References
- Miller DA, Rabello YA, Paul RH. The modified biophysical profile: antepartum testing in the 1990s. Am J Obstet Gynecol. 1996;174(3):812-17.
- Dahmus MA, Amon E. The Biophysical Profile. In: Global Library of Women’s Medicine, chapter 77. London: GLOWM.
- The ObG Project. Antenatal Fetal Surveillance: Indications and Timing, citing ACOG Committee Opinion 828 and the ACOG Practice Bulletin on antepartum fetal surveillance.
- Nabhan AF, Abdelmoula YA. Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. Cochrane Database Syst Rev. 2008;(3):CD006593. doi:10.1002/14651858.CD006593.pub2
- Dayal AK, Manning FA, Berck DJ, et al. Fetal death after normal biophysical profile score: an eighteen-year experience. Am J Obstet Gynecol. 1999;181(5 Pt 1):1231-6.
Not medical advice. For healthcare professionals and education. Reference intervals vary by laboratory and assay — always use your own laboratory's. Never base a dose or a treatment decision on this page alone. Full disclaimer at calcengines.com/disclaimer/